"It passes through our bodies, our cells and every living organism on the planet, yet we know surprisingly little about ...

Neurodegenerative diseases slowly damage the brain and nervous system, affecting millions of people worldwide. Two of the most common conditions are Alzheimer’s disease (AD) and Parkinson’s disease ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Tiny, metallic, flower-shaped nanoparticles may offer fresh hope for ...

Alzheimer's-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a Parkinson's-related protein, according to a Mayo Clinic study published in JAMA Network ...

Earth's magnetic field permeates all living organisms, and exploring its effects could unlock new treatments for Parkinson's ...

Researchers in Japan discovered that Parkinson’s patients diagnosed in their 80s are far more likely to show signs of amyloid buildup, a hallmark of Alzheimer’s, even without dementia symptoms. The ...

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide. Published in the Journal of Neuroscience, new research from the ...

Despite their differences, Alzheimer’s disease and Parkinson’s disease share several risk factors and mechanisms of neuronal damage. Both also feature a phase that precedes the appearance of symptoms ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain cells. The process of proteins spontaneously clumping is called ...

A new experimental drug for Alzheimer's disease has shown encouraging results in helping some patients maintain their memory and thinking abilities, according to findings from a recent clinical trial.

Tear fluid contains several markers of diseases, such as Parkinson’s disease, Alzheimer’s disease, diabetes, and cancer.